Clinical Trials Logo

Filter by:
NCT ID: NCT03642288 Active, not recruiting - CRE-induced SBO Clinical Trials

The Use of Gastrografin in Chronic Radiation Enteropathy With Small Bowel Obstruction

Start date: April 1, 2014
Phase: N/A
Study type: Interventional

Chronic radiation enteropathy (CRE) is a major issue for long-term cancer survivors. The aim of this study was to clarify the diagnostic and therapeutic effect of the Gastrografin (GG) challenge for patients with CRE induced small bowel obstruction SBO.

NCT ID: NCT04812353 Active, not recruiting - Clinical trials for Foot and Ankle Osteotomy

Foot and Ankle Arthrodesis or Osteotomy With Io-Fix Type Fixation

Start date: April 1, 2014
Phase: N/A
Study type: Interventional

The recovery of foot and ankle arthrodesis and osteotomy is still plagued by the problem of delayed consolidation or even pseudo-arthrosis. To date, the foot and ankle unit of UZ Leuven is using a state of the art system, called the Io-Fix system, to optimize the biomechanical stability. However, the current literature lacks studies assessing and quantifying the advantages of the Io-Fix system. Objective presentations about the use of, and (early) results are currently missing. Therefore, the investigators want to take their responsibility to objectively investigate whether they can confirm and quantify the expected positive results of using the Io-Fix system. Subsequently, the investigators want to search for eventual unexpected problems with Io-Fix.

NCT ID: NCT02286089 Active, not recruiting - Clinical trials for Age-Related Macular Degeneration

Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration

Start date: April 1, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

The main objective of the study is evaluation of the safety and tolerability of OpRegen - Human embryonic stem cell-derived retinal pigment epithelial (RPE) cells. The study will also include initial exploration of the ability of transplanted OpRegen cells to engraft, survive, and moderate disease progression.

NCT ID: NCT02304614 Active, not recruiting - Breast Cancer Clinical Trials

The Use of 3D Surface Imaging in the Objective Assessment of Breast Conserving Therapy

3DBCT
Start date: April 1, 2015
Phase:
Study type: Observational

3D surface imaging has been used in the objective evaluation of cosmetic outcome of oncoplastic procedures such as breast reconstruction and lipofilling, however there is only one article published relating to Breast Conserving Therapy (BCT). The aim of this study is to assess the use 3D surface imaging as a tool in the assessment of symmetry of outcome following breast conserving therapy. The results of the surface imaging will be correlated with patient satisfaction, using the BREAST-Q, which is a validated patient questionnaire and correlated with panel assessment by an independent panel of two surgeons, one clinical oncologist and one breast care nurse.

NCT ID: NCT02360137 Active, not recruiting - Clinical trials for Carotid Artery Plaque

Atherosclerotic Plaque Characteristics Associated With a Progression Rate of the Plaque in Carotids and a Risk of Stroke

ANTIQUE
Start date: April 1, 2015
Phase:
Study type: Observational

Atherosclerosis is the most common cause of stroke. The aims of the project are to compare the visual and digital analysis of sonographic images of atherosclerotic plaque in carotids in vivo, in vitro and with a histological composition of the plaque obtained from patients indicated to carotid endarterectomy, to compare the characteristics of symptomatic and asymptomatic atherosclerotic plaques and, subsequently to verify a hypothesis that ultrasound can identify the sonographic plaque characteristics associated with an increased risk of plaque progression and of ischemic stroke (unstable plaque) in patients with carotid atherosclerosis. Identifying of the sonographic characteristics of unstable plaque will allow to improve indication criteria for carotid endarterectomy or stenting and also potential changing of a drug therapy in patients with unstable plaque in the future. Cost efficiency and availability of duplex ultrasound equipment may enable to improve diagnosis of unstable plaque using this new plaque characteristics evaluation in the majority of patients with carotid plaques.

NCT ID: NCT02425761 Active, not recruiting - Hydrocephalus Clinical Trials

The CSF Shunt Entry Site Trial

Start date: April 1, 2015
Phase: Phase 3
Study type: Interventional

The purpose of the study is to compare the survival time (time to first shunt failure) of ventriculoperitoneal (VP) shunts inserted through an anterior entry site with those inserted through a posterior entry site in children. Shunt entry site is the location on the head that the shunt catheter enters the brain on its path to the fluid-filled spaces in the brain, the ventricles. Entry sites can be anterior or posterior.

NCT ID: NCT02546232 Active, not recruiting - Breast Cancer Clinical Trials

Improved Breast Cancer Therapy (I-BCT-1) in the Neoadjuvant and Metastatic Setting

Start date: April 1, 2015
Phase: Phase 2
Study type: Interventional

The purpose of the study is to investigate the molecular biology of the tumor in relation to treatment response to chemotherapy, in particular paclitaxel compared to the combination paclitaxel and carboplatin. The study is carried out in two different, separate cohorts: Cohort I: Patients with large primary breast cancer (> 2.0 cm) including locally advanced disease, are treated with weekly paclitaxel for 12 weeks, before continuing on anthracycline containing regimen for another 12 weeks before surgery. Patient are randomized 1:1 to receive carboplatin in addition to paclitaxel for the first 12 weeks of the treatment. Cohort II: Patients with metastatic disease, available for biopsies before and during therapy are included to receive paclitaxel for 24 weeks. Patients are randomized 1:1 to receive paclitaxel alone or paclitaxel in combination with carboplatin.

NCT ID: NCT03268772 Active, not recruiting - Soft Tissue Sarcoma Clinical Trials

PLD and IFO As First-line Treatment for Patients With Advanced or Metastatic STS

Start date: April 1, 2015
Phase: Phase 2
Study type: Interventional

This study is designed to evaluate the efficacy and safety of pegylated liposomal doxorubicin (PLD) combined with ifosfamide (IFO) for the first-line treatment of patients with advanced or metastatic soft tissue sarcoma (STS).

NCT ID: NCT03607604 Active, not recruiting - Clinical trials for Diabetes Mellitus, Type 2

Application of UCPCR as a Testing Tool for Identification of MODY Patients in the UAE

Start date: April 1, 2015
Phase:
Study type: Observational

The study aims to investigate the validity of 2 hour post-prandial UCPCR test in paediatric and adult patients with diabetes duration greater than 2 and 5 years, respectively, for the purposes of distinguishing between patients with type 1 diabetes and MODY in the UAE population.

NCT ID: NCT04058730 Active, not recruiting - Clinical trials for Type 2 Diabetes Mellitus

Comparative Interventional Study to Evaluate the Role of LRYGBP, LSG & SMM

Start date: April 1, 2015
Phase: N/A
Study type: Interventional

A Comparative Interventional Study to Evaluate the Role of Laparoscopic Roux-en-Y Gastric Bypass (LRYGBP), Laparoscopic Sleeve Gastrectomy (LSG) and Standard Medical Management (SMM) in Patients of Type II Diabetes Mellitus (DM) and Body Mass Index ( BMI) Between 27.5 - 32.5 kg / m²."